Cerebral venous thrombosis

被引:32
作者
Agostoni, Elio [1 ,2 ]
Aliprandi, Angelo [1 ,2 ]
Longoni, Marco [1 ,2 ]
机构
[1] Alessandro Manzoni Hosp, Div Neurol, Dept Neurosci, Lecce, Italy
[2] Univ Milano Bicocca, Milan, Italy
关键词
anticoagulation; cerebral venous thrombosis; headache; stroke;
D O I
10.1586/ERN.09.3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebral venous thrombosis (CVT) was formerly considered a rare disorder, associated with an unfavorable outcome. More recent data based on modern imaging techniques, however, have changed our perception of this disorder. The use of angiography and, especially, MRI have allowed an early diagnosis and have proved that the incidence of CVT is, in fact, higher than previously thought, approximately 3-4 cases per million people per year, and that the majority of patients have a favorable outcome. At present, the most frequent causes are oral contraceptives assumption and pregnancy/puerperium; as a consequence, 75% of patients are females. CVT may cause isolated intracranial hypertension or lead to an ischemic stroke, which does not follow the distribution of an arterial vessel and has a relevant vasogenic edema. Venous strokes often have a hemorrhagic component, ranging from small petechiae to an actual intracerebral hemorrhage; the latter is associated with a worse clinical course. The clinical presentation of CVT is hihgly variable and includes patients with just a mild headache, others with focal neurological deficits and a few with a dramatic syndrome with coma; seizures are a frequent presenting symptom. The best radiological examination to confirm the suspicion of CVT is MRI of the brain, which can both demonstrate parenchymal lesions and directly show evidence of sinus occlusions. The available evidence suggests that anticoagulants are effective in reducing mortality and dependency in CVT patients; the possible role of systemic or localized thrombolysis is still to be established.
引用
收藏
页码:553 / 564
页数:12
相关论文
共 57 条
[11]  
CICCONE A, 2004, COCHRANE DB SYST REV, V1
[12]   Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis [J].
Corvol, JC ;
Oppenheim, C ;
Manaï, R ;
Logak, M ;
Dormont, D ;
Samson, Y ;
Marsault, C ;
Rancurel, G .
STROKE, 1998, 29 (12) :2649-2652
[13]   A negative D-dimer assay does not rule out cerebral venous thrombosis - A series of seventy-three patients [J].
Crassard, I ;
Soria, C ;
Tzourio, C ;
Woimant, F ;
Drouet, L ;
Ducros, A ;
Bousser, MG .
STROKE, 2005, 36 (08) :1716-1719
[14]   Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis [J].
de Bruijn, SFTM ;
Stam, J .
STROKE, 1999, 30 (03) :484-488
[15]   Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives [J].
de Bruijn, SFTM ;
Stam, J ;
Vandenbroucke, JP .
LANCET, 1998, 351 (9113) :1404-1404
[16]  
de Bruijn SFTM, 1998, CEREBRAL VENOUS SINU
[17]   Thunderclap headache as first symptom of cerebral venous sinus thrombosis [J].
deBruijn, SFTM ;
Stam, J ;
Kappelle, LJ .
LANCET, 1996, 348 (9042) :1623-1625
[18]  
DORMONT D, 1994, J NEURORADIOLOGY, V21, P81
[19]   EFNS guideline on the treatment of cerebral venous and sinus thrombosis [J].
Einhaeupl, K. ;
Bousser, M. -G. ;
de Bruijn, S. F. T. M. ;
Ferro, J. M. ;
Martinelli, I. ;
Masuhr, F. ;
Stam, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (06) :553-559
[20]   HEPARIN TREATMENT IN SINUS VENOUS THROMBOSIS [J].
EINHAUPL, KM ;
VILLRINGER, A ;
MEISTER, W ;
MEHRAEIN, S ;
GARNER, C ;
PELLKOFER, M ;
HABERL, RL ;
PFISTER, HW ;
SCHMIEDEK, P .
LANCET, 1991, 338 (8767) :597-600